Findings from the phase 3 randomized CABASTY clinical trial “may be practice changing,” investigators reported. Biweekly vs triweekly cabazitaxel for mCRPC in men aged 65 years or older has similar efficacy but is associated with a lower risk for neutropenia and/or neutropenic complications.
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix) for Imaging of Kidney Cancer philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.
MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it.
Eight Cancer Survivors Celebrate Life and Perseverance on City of Hope s Rose Parade Float streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.